Inventor · disambiguated record
Somasekar Seshagiri
Also filed as: SESHAGIRI SOMASEKAR
11 granted patents·23 pending applications·78 citations·filing 2003–2024
90Inventor score
Files withGENENTECH INC20SESHAGIRI SOMASEKAR6ANTLERA THERAPEUTICS INC3BAZAN JOSE F1HOEFLICH KLAUS P1
Top patents by PatentIndex Score
34 records- 0194US7932026B2EGFR mutationsGENENTECH INC·Filed 2005·Granted Apr 26, 2011·24 cites·24 claims
- 0294US7576185B2PRO34128 antibodiesGENENTECH INC·Filed 2007·Granted Aug 18, 2009·16 cites·5 claims
- 0392US7960118B2EGFR mutationsGENENTECH INC·Filed 2008·Granted Jun 14, 2011·16 cites·5 claims
- 0488US8232062B2EGFR mutationsSESHAGIRI SOMASEKAR·Filed 2011·Granted Jul 31, 2012·9 cites·20 claims
- 0586US2025281489A1Biomarkers for predicting sensitivity to cancer treatmentsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0684US7642242B2PRO34128 polypeptidesGENENTECH INC·Filed 2007·Granted Jan 5, 2010·2 cites·7 claims
- 0782US8232053B2EGFR mutationsSESHAGIRI SOMASEKAR·Filed 2011·Granted Jul 31, 2012·4 cites·10 claims
- 0877US8680041B2Genetic variations associated with tumorsKAN ZHENGYAN·Filed 2007·Granted Mar 25, 2014·3 cites·10 claims
- 0975US8987266B2EGFR mutationsGENENTECH INC·Filed 2013·Granted Mar 24, 2015·1 cites·15 claims
- 1068US9631240B2Genetic variations associated with tumorsGENENTECH INC·Filed 2014·Granted Apr 25, 2017·1 cites·9 claims
- 1165US7247446B2PRO34128 nucleic acidsGENENTECH INC·Filed 2003·Granted Jul 24, 2007·2 cites·12 claims
- 1265US2018235968A1Egfr mutationsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1365US2024228631A9Tetravalent FZD and WNT Co-receptor Binding Antibody Molecules and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1463US2020138944A1Mit biomarkers and methods using the sameGENENTECH INC·Filed 2019·Application pending·0 cites
- 1561US8535670B2Method of treating colorectal cancer tumorSESHAGIRI SOMASEKAR·Filed 2012·Granted Sep 17, 2013·0 cites·5 claims
- 1659US2023118983A1Tetravalent FZD and WNT Co-receptor Binding Molecules and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1759US2018360835A1Biomarkers for predicting sensitivity to cancer treatmentsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1857US2025270332A1Tetravalent FZD and WNT Co-Receptor Binding Antibody Molecules and Uses ThereofANTLERA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1956US2021025008A1R-Spondin Translocations and Methods Using the SameGENENTECH INC·Filed 2020·Application pending·0 cites
- 2056US2015290196A1Egfr mutationsGENENTECH INC·Filed 2015·Application pending·0 cites
- 2155US2018250394A1Mit biomarkers and methods using the sameGENENTECH INC·Filed 2016·Application pending·0 cites
- 2253US2014031259A1Biomarkers for predicting sensitivity to cancer treatmentsLIN KUI·Filed 2012·Application pending·0 cites
- 2353US2020172631A1Erbb2/her2 mutations in the transmembrane or juxtamembrane domainGENENTECH INC·Filed 2019·Application pending·0 cites
- 2453US2017065588A1Biomarkers for predicting sensitivity to cancer treatmentsGENENTECH INC·Filed 2016·Application pending·0 cites
- 2552US2010092965A1Genetic variations associated with tumorsSESHAGIRI SOMASEKAR·Filed 2007·Application pending·0 cites
- 2652US2010285016A1PRO34128 nucleic acidsGENENTECH INC·Filed 2009·Application pending·0 cites
- 2752US2010034836A1Compositions and methods for the diagnosis and alleviation of tumorHOEFLICH KLAUS P·Filed 2006·Application pending·0 cites
- 2851US2010034821A1Genetic variations associated with tumorsBAZAN JOSE F·Filed 2008·Application pending·0 cites
- 2948US2013209473A1R-spondin translocations and methods using the sameGENENTECH INC·Filed 2013·Application pending·0 cites
- 3048US2014298493A1PIK3CA H1047R Knock-In Non-Human Animal Breast Cancer ModelSESHAGIRI SOMASEKAR·Filed 2012·Application pending·0 cites
- 3148US2023203466A1Ace2 receptor polymorphisms and varying susceptibility to sars-cov-2, methods for diagnosis and treatmentMEDGENOME INC·Filed 2021·Application pending·0 cites
- 3242US2008220471A1Vectors and Methods Using SameGENENTECH INC·Filed 2006·Application pending·0 cites
- 3340US2013324419A1Methods for nucleic acid capture and sequencingSESHAGIRI SOMASEKAR·Filed 2011·Application pending·0 cites
- 3439US2013195870A1ERBB3 Mutations In CancerGENENTECH INC·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →